Insulin aspart has a shorter duration of action than human insulin over a wide dose-range. Diabetes Obes Metab. 2013;15:77- 83.Nosek L, Roggen K, Heinemann L, Gottschalk C, Kaiser M, Arnolds S, et al. Insulin aspart has a shorter duration of action than human insulin over a wide ...
Duration of action of the insulin analogue B28Asp in comparison to regular insulin. Diabetes 1996 May; 45 Suppl. 2: 139 Google Scholar Kang S, Brange J, Burch A, et al. Absorption kinetics and action profiles of subcutaneously administered insulin analogues (AspB9GluB27, AspB10, AspB28)...
Insulin aspart has a shorter duration of action than human insulin over a wide dose-range AimsRegular human insulin (RHI) at high doses shows prolongation of its duration of action potentially leading to late postprandial hypoglycaemia. This stu... L Nosek,K Roggen,L Heinemann,... - 《...
胰岛素诺和锐30r的使用说明书（Insulin aspart 30R manual）Novorapid 30 flexpen - only to find the "charge", deal with it Drug name: novorapid 30 flexpen Insulin Aspart 30 Injection Novorapid 30 FlexPen Description: novorapid 30 flexpen (for the treatment of diabetes mellitus) can better ...
Risk Factors for Hypoglycemia:The risk of hypoglycemia after an injection is related to the duration of action of the insulin and, in general, is highest when the glucose lowering effect of the insulin is maximal. As with all insulins, the glucose lowering effect time course of NovoLo...
Nosek L, Heinemann L, Kaiser M, et al. No increase in the duration of action with rising doses of insulin aspart [abstract]. Diabetologia 2003 Aug; 46 Suppl. 2: 268 Google Scholar Nosek L, Heinemann L, Kaiser M, et al. No increase in the duration of action with rising doses of ...
Risk Factors for Hypoglycemia:The risk of hypoglycemia after an injection is related to the duration of action of the insulin and, in general, is highest when the glucose lowering effect of the insulin is maximal. As with all insulins, the glucose lowering effect time course of NovoLog®Mix...
Insulin Aspart: A Review of its Use in the Management of Type 1 or 2 Diabetes Mellitus. Insulin aspart (NovoRapid((R)), NovoLog((R))) is a short-acting insulin analogue, which has a faster onset and shorter duration of action than regular huma... NA Reynolds,AJ Wagstaff - 《Drugs》...
Insulin aspart achieves higher peak insulin concentrations in less time and with a shorter duration of action than regular human insulin. CONCLUSIONS: Insulin aspart is a convenient premeal insulin for use by patients requiring mealtime insulin. Furthermore, due to favorable pharmacokinetics, insulin ...
Known hypersensitivity to insulin aspart or any ingredient in the formulation. Hypoglycemic episodes.Warnings/PrecautionsWarningsFormulation ConsiderationsMore rapid onset and shorter duration of action than insulin human (regular). Patients with type 1 diabetes mellitus generally require a longer-acting ...